Ask AI

Test First, Treat Right: Advancing ROS1 Detection and Targeted Therapy Selection in NSCLC

Improve your ability to care for patients with thoracic malignancies who are eligible for fusion protein–targeted therapy through a certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

Activities

Understanding ROS1pos NSCLC
Understanding ROS1-Positive NSCLC: Biology, Biomarker Testing, and Evolving Clinical Evidence
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by an educational grant from Nuvation Bio Inc.

Nuvation Bio Inc.